Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ImmunoGen Inc (NASDAQ:IMGN)

2.47
Delayed Data
As of 4:00pm ET
 0.00 / 0.00%
Today’s Change
1.51
Today|||52-Week Range
9.78
+21.08%
Year-to-Date
ImmunoGen, Inc.: Waiting to Move FORWARD
Feb 21 / MotleyFool.com - Paid Partner Content
ImmunoGen (IMGN) Reports Wider-than-Expected Loss
Feb 17 / Zacks.com - Paid Partner Content
ImmunoGen Posts Wider-than-Expected Loss; Sales Down Y/Y
Feb 20 / Zacks.com - Paid Partner Content
What's in Store for ImmunoGen (IMGN) this Earnings Season?
Feb 13 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close2.47
Today’s open2.47
Day’s range2.45 - 2.51
Volume861,718
Average volume (3 months)1,761,009
Market cap$215.6M
Dividend yield--
Data as of 4:00pm ET, 02/22/2017

Growth & Valuation

Earnings growth (last year)-135.21%
Earnings growth (this year)--
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-29.86%
P/E ratioNM
Price/Sales4.46
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ENZYEnzymotec Ltd+0.10+1.11%
OSIROsiris Therapeutics ...-0.40-6.81%
CGENCompugen Ltd0.000.00%
CYADCelyad SA+0.62+2.98%
Data as of 4:00pm ET, 02/22/2017

Financials

Next reporting dateMay 31, 2017
EPS forecast (this quarter)-$0.48
Annual revenue (last year)$60.0M
Annual profit (last year)-$144.8M
Net profit margin-241.35%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark J. Enyedy
Chief Financial Officer &
Executive Vice President
David B. Johnston
Corporate headquarters
Waltham, Massachusetts

Forecasts


Search for Jobs